Alvogen Acquires Five Hormonal Products In Russia And CIS
PINE BROOK, N.J.--(BUSINESS WIRE)--Alvogen, today announced that it has acquired five hormonal branded products from Bayer Pharma AG in Russia and CIS.
The products acquired are Klimonorm (Hormone replacement therapy), Progynova (Hormone replacement therapy), Triquilar ( Female contraception) and Microgynon (Female contraception) and Climene (Hormone replacement therapy).
Help employers find you! Check out all the jobs and post your resume.
The products acquired are Klimonorm (Hormone replacement therapy), Progynova (Hormone replacement therapy), Triquilar ( Female contraception) and Microgynon (Female contraception) and Climene (Hormone replacement therapy).
Help employers find you! Check out all the jobs and post your resume.